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Abstract
Background: Amino acid mutations in a large number of human proteins are known to be
associated with heritable genetic disease. These disease-associated mutations (DAMs) are known
to occur predominantly in positions essential to the structure and function of the proteins. Here,
we examine how the relative perpetuation and conservation of amino acid positions modulate the
genome-wide patterns of 8,627 human disease-associated mutations (DAMs) reported in 541
genes. We compare these patterns with 5,308 non-synonymous Single Nucleotide Polymorphisms
(nSNPs) in 2,592 genes from primary SNP resources.
Results: The abundance of DAMs shows a negative relationship with the evolutionary rate of the
amino acid positions harboring them. An opposite trend describes the distribution of nSNPs. DAMs
are also preferentially found in the amino acid positions that are retained (or present) in multiple
vertebrate species, whereas the nSNPs are over-abundant in the positions that have been lost (or
absent) in the non-human vertebrates. These observations are consistent with the effect of
purifying selection on natural variation, which also explains the existence of lower minor nSNP
allele frequencies at highly-conserved amino acid positions. The biochemical severity of the inter-
specific amino acid changes is also modulated by natural selection, with the fast-evolving positions
containing more radical amino acid differences among species. Similarly, DAMs associated with
early-onset diseases are more radical than those associated with the late-onset diseases. A small
fraction of DAMs (10%) overlap with the amino acid differences between species within the same
position, but are biochemically the most conservative group of amino acid differences in our
datasets. Overlapping DAMs are found disproportionately in fast-evolving amino acid positions,
which, along with the conservative nature of the amino acid changes, may have allowed some of
them to escape natural selection until compensatory changes occur.
Conclusion: The consistency and predictability of genome-wide patterns of disease- associated
and neutral amino acid variants reported here underscores the importance of the consideration of
evolutionary rates of amino acid positions in clinical and population genetic analyses aimed at
understanding the nature and fate of disease-associated and neutral population variation.
Establishing such general patterns is an early step in efforts to diagnose the pathogenic potentials
of novel amino acid mutations.
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The association of mutations with specific human inher-
ited diseases has been known for over five decades [1].
These mutations can be single nucleotide changes (point
mutations), insertion or deletion of nucleotides (indels),
or gross chromosomal rearrangements; furthermore, they
may occur in protein-coding and in non-coding regula-
tory regions. Of all known gene lesions associated with
disease, approximately half are point mutations that
change the encoded amino acid [2]. Statistical analyses of
these amino acid mutations are the most tractable,
because their properties and tendencies can be predicted
based on the long-term evolutionary history of their loca-
tions by comparative genomics [3-9].
Evolutionary analyses of disease-associated mutations
(DAMs) have revealed a number of trends. They are over-
abundant at positions that have remained unchanged in
species that diverged hundreds of millions of years ago [4-
6,8,9], and there is a general under-abundance of DAMs
in positions that show any potential to change [3,5].
DAMs are more radical in terms of the differences in their
biochemical properties from the normal amino acids, as
compared to the differences observed between species
[3,5,10]. Furthermore, only a very small fraction of
known DAMs are identical to the inter-specific substitu-
tions at the same positions [5,11-13]. In addition, the evo-
lutionary history of amino acid positions and the long-
term substitution patterns observed in the proteins have
been employed with varying degrees of success in predict-
ing the disease propensity of mutations [3,5,7,9,14-16].
However, many of the patterns mentioned above have
been elucidated from the analysis of a limited number of
proteins or mutations. With the recent expansion of
genome and population variation data, it is now possible
to establish molecular evolutionary anatomies of DAMs at
a genome-scale and to use different measures of the inten-
sity of natural selection at amino acid positions over the
long term history of proteins. Although the significance of
the biochemical severity of amino acid changes and their
association with human diseases is well-appreciated, the
possible relationship between the extent of biochemical
dissimilarity of DAMs and the severity of human diseases
(in terms of the time of onset of diseases) needs to be fur-
ther explored. Similarly, the pattern of occurrence of non-
synonymous polymorphisms (nSNPs) at sites evolving
with vastly different intensities of natural selection are yet
to be contrasted with those seen for DAMs.
Therefore, we undertook a genomic-scale analysis to elu-
cidate the global evolutionary trends of rare Mendelian
DAMs and nSNPs present in human proteins. We specifi-
cally examined the following questions: (1) What is the
relative distribution of DAMs and nSNPs at positions that
evolve with different rates? (2) Does the degree of reten-
tion of amino acid positions in non-human vertebrates
show a relationship with the frequency of occurrence of
DAMs and nSNPs? (3) How are the allele and genotype
frequencies of nSNPs modulated by evolutionary variabil-
ity of amino acid positions? (4) What is the relationship
between the severity of inter-specific amino acid substitu-
tions and the level of evolutionary conservation of posi-
tions harboring them? (5) What is the relationship
between the biochemical severity of DAMs and the timing
of the onset of different diseases? (6) To what extent does
the evolutionary rate of a position explain the observed
overlap between the inter-specific substitutions and
DAMs? In order to answer these questions, we compared
and contrasted available information on disease-associ-
ated amino acid mutation data, human population poly-
morphism data, and inter-specific amino acid difference
data.
Results
The evolutionary conservation of an amino acid position
in a protein was measured in two ways. First, we estimated
the rate at which amino acid substitutions have occurred
at each position (Rate index). Secondly, we assessed the
existence of a position in homologous proteins in species
distantly and closely related to humans (Indel index).
These two indices were estimated for human proteins
where at least one DAM or nSNP has been reported in the
public databanks (see Methods).
Both the Rate and Indel indices are estimated using mul-
tiple sequence alignments consisting of human proteins
and their three closest homologs in the fully sequenced
vertebrates (another mammal [Mus musculus], a bird [Gal-
lus gallus], and a bony fish [Takifugu rubripes]). To estimate
the rate index, we used a Maximum Likelihood (ML) pro-
cedure with a discrete-Gamma function to model differ-
ences in evolutionary rates among positions, while a JTT
model was employed to account for differences in substi-
tution probabilities between 20 amino acids [17,18]. The
ML procedure indicated significant rate variation among
positions (gamma shape parameter = 0.65) in all analyses,
and predicted evolutionary rate at each position. They
were arranged in eight rate categories (see Table 1). We
also categorized positions using a simple Poisson model
of amino acid substitution for estimating evolutionary
rates, because measures of biochemical severity are known
to be correlated with the JTT model. We have presented
results from the JTT-model-based analyses only, because
both methods produced extremely similar results.
Our Indel index is simply the number of times a human
amino acid position was missing a homolog in the multi-
ple sequence alignment with three other species. Its value
ranged from zero to three, with the smallest number rep-Page 2 of 9
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sophisticated index with eight categories that weighted
indels based on evolutionary closeness of the species pro-
duced results similar to those reported here (results not
shown).
Opposite patterns of occurrence of DAMs and nSNPs
The relationship of the ratio of observed-to-expected
counts of positions harboring DAMs and nSNPs in eight
evolutionary rate classes is shown in Figure 1 for all posi-
tions that do not contain any insertion-deletions. An anal-
ysis of the distribution of 7,966 DAMs in 335,520
positions establishes their over-abundance in the slowest
evolving positions (P << 0.01; Figure 1A). The distribu-
tion of positions containing 4,022 nSNPs in 1,619,701
positions shows an opposite trend, as they are signifi-
cantly under-abundant at the most highly conserved sites
(P << 0.01; Figure 1B). The observed tendencies may not
be attributed to differences in mutational patterns among
sites in different rate categories, because the observed-to-
expected frequencies of 413 synonymous SNPs in the
HapMap database (251,828 positions) show an expected
random pattern (P > 0.05; Figure 1C).
An analysis of all 8,627 DAMs in 436,360 positions
clearly shows that positions that have indels in other spe-
cies contain fewer than expected DAMs (P < 0.01; Figure
2A). In contrast, the distribution of 5,308 nSNPs in
2,180,746 positions reveals an excess of nSNPs at posi-
tions with many indels (P < 0.01; Figure 2B). Therefore,
DAMs and nSNPs show exactly opposite trends. Again,
this difference cannot be attributed to average differences
in mutation rates, because positions with many indels do
not contain an excess of synonymous SNPs as seen in an
analysis of 528 sSNPs in 353,524 positions (P > 0.05; Fig-
ure 2C).
Earlier onset diseases associate with more radical amino 
acid mutations
We examined the average of biochemical (Grantham) dis-
tances for DAMs, nSNPs, and amino acid differences
observed between species [3,5,19]. The average Grantham
distance for 7,966 DAMs is 92.1, which is more than 50%
Table 2: Frequency of disease-associated and non-synonymous (nSNP) mutations in different Indel index categories
Indel index1 Disease-associated genes (541) Other genes (2592)
No. of positions DAMs No. of positions nSNPs
0 360,070 7,966 1,781,946 4,022
1 58,452 585 312,656 971
2 15,356 69 69,298 238
3 2,482 7 16,846 77
Total 436,360 8,627 2,180,746 5,308
1 -Number of nonhuman vertebrate proteins containing an alignment gap.
Table 1: Frequency of disease-associated and non-synonymous (nSNPs) mutations in different evolutionary rate categories
Rate index (estimated rate range) Disease-associated genes (523) Other genes (2264)
No. of positions DAMs No. of positions nSNPs
0 (0.000–0.125) 90,971 3,047 339,162 510
1 (0.126–0.250) 95,991 2958 546,466 622
2 (0.251–0.375) 39,751 649 203,711 688
3 (0.376–0.500) 41,570 618 208,192 588
4 (0.501–0.625) 18,235 240 96,819 343
5 (0.626–0.750) 21,490 227 108,584 571
6 (0.751–0.875) 16,061 145 72,280 395
7 (0.876–1.000) 11,451 82 44,487 305
Total 335,520 7,966 1,619,701 4,022
NOTE: – The evolutionary rates of amino acid positions obtained from Maximum Likelihood analysis ranges from 0.32 to 3.4. For simplicity, we 
normalized each rate value by dividing by 3.4 in order to make the scale from 0.094–1.000. The amino acid positions were then grouped into eight 
categories based on their relative rate of evolution with an interval of 0.125.Page 3 of 9
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Relationship of the observed-to-expected numbers of mutations in positions with different numbers of in elsFigure 2
Relationship of the observed-to-expected numbers of 
mutations in positions with different numbers of indels. 
(A) Disease-associated mutations (red). (B) Non-synonymous 
SNPs (blue). (C) Synonymous SNPs (black). The indel index in the 
X-axis indicates the number of alignment gaps in the three nonhu-
man vertebrates included in the study. Specifically, the category 0 
includes only the amino acid positions that have no indel in the 
multiple sequence alignments. Similarly 1, 2, and 3 includes the 
positions that have one, two, and three indels in the nonhuman 
vertebrate sequences with respect to the human sequence. Devia-
tions from the random expectations are significant for DAMs at P 
< 0.01 (χ2 = 599, df = 3), significant for non-synonymous SNPs at P 
< 0.01 (χ2 = 143, df = 3), and not significant for synonymous SNPs 
(P > 0.05; χ2 = 3.7, df = 3).
Relationship of the observed-to-expected numbers of muta-tions in differen  ev lutionary rate categoriesFigure 1
Relationship of the observed-to-expected numbers of 
mutations in different evolutionary rate categories. 
(A) Disease-associated mutations, DAMs (red). (B) Non-syn-
onymous SNPs (blue), nSNPs. (C) Synonymous SNPs, sSNPs 
(black). The mid-values of the position rate categories are 
given in the X-axis (see also Table 1). The expected number 
of mutations at the amino acid positions belonging to a given 
rate index category, i, was computed as Ei = (ni/N) × M, 
where ni is the number of amino acid positions belonging to 
the ith category, N is the total number of amino acid posi-
tions, and M is the total number of disease mutations (or 
SNPs) used in the analysis. The significance of the deviations 
of the observed values from the expected was evaluated by a 
χ2 test. The significance of the deviations from the random 
expectations for DAMs was P << 0.01 (χ2 = 1318, df = 7), for 
non-synonymous SNPs was P << 0.01 (χ2 = 1586, df = 7); and 
for synonymous SNPs was P > 0.05 (χ2 = 7.2, df = 7). The 
observed correlations are significant at a 1% level for DAMs 
(R2 = 0.95) and nSNPs (R2 = 0.92), and the correlation is insig-
nificant for synonymous SNPs (R2 = 0.21).
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ences (66.6) and nSNPs (65.0) (Table 3). The similarity of
the Grantham distance for between species "neutral" dif-
ferences and within species "neutral" variations is remark-
able and indicates that, on an average, the biochemical
nature of polymorphisms within a population is a snap-
shot of the differences that exist among species.
DAMs can be further analyzed in the context of the timing
of the diseases' onset. Diseases with onset at early stages of
the human life cycle will be more harmful than those that
are late-onset, because the former will affect fecundity
more severely and will modulate the biochemical severity
of DAMs. Indeed, the biochemical severity of mutations
associated with diseases that manifest the earliest is 17%
higher than the latest-onset diseases (P < 0.05). Even
though the average differences between categories are
small, there is a clear cut negative trend (Mann-Whitney
U-test, P < 0.001; Figure 3A).
The average biochemical severity of DAMs was also ana-
lyzed in the context of the evolutionary rate of the posi-
tions, which do not show a significant monotonic trend
(P = 0.21). In contrast, a positive relationship was
observed between the evolutionary rate and the biochem-
ical distances for inter-specific differences (Figure 3B),
indicating that radical changes in highly variable posi-
tions are more tolerated than in positions with low evolu-
tionary variability. This happens because more dissimilar
amino acid changes will experience a higher intensity of
purifying selection than the changes that involve highly
similar amino acids.
Discussion
We have observed opposite patterns of the distribution of
disease-associated and non-synonymous variation in
amino acid positions with different evolutionary rates, as
well as indel propensities. These patterns are consistent
with the predictions of the neutral theory of molecular
evolution, because the purifying selection will eliminate
mutations from functionally important positions more
effectively. Both the rate index and indel index produce
similar trends, because the natural selection will maintain
the amino acid type and will retain the amino acid posi-
tion among species.
It is important to note that we have considered different
types of amino acids that are associated with disease
mutations at different amino acid positions, and we have
not considered the population frequency of DAMs. This is
because allele frequencies for a vast majority of DAMs are
either very small or are not known with great precision
[20]. In order to make a direct comparison between DAMs
and nSNPs, we repeated our analyses by using only lower-
frequency HapMap nSNPs (allele frequency < 0.10),
which confirmed the patterns reported in Figure 1B (P <
0.01).
Conversely, we looked for DAMs that occur in appreciable
frequencies (> 10-6; [20]) and found them to be largely
associated with late-onset diseases (post puberty). These
mutations are not over-abundant at evolutionarily con-
served positions (P = 0.7; 430 mutations), and they are
biochemically less radical (Figure 3A). They are often
associated with common diseases such as the hyperten-
sion, diabetes, and osteoporosis. The late onset of these
diseases will result in a small affect on fecundity, which
may explain why the positions harboring these DAMs do
not have evolutionary imprints similar to those observed
for other DAMs.
The invocation of natural selection to explain the
observed distributions of DAMs and nSNPs makes a
number of predictions that can be tested using the availa-
ble information on nSNP allele frequencies from the Hap-
Map data. As expected, minor allele frequencies of nSNPs
are positively correlated with the evolutionary rate,
because positions with higher long-term evolutionary
rates are under lower purifying selection (R2 = 0.85, P <
0.01; 935 nSNPs). The average minor allele frequency of
the nSNPs at the highly conserved sites is less than half of
that observed at the highly variable sites (Figure 4A).
The occurrence of homozygotes of minor alleles is also
expected to correlate positively with evolutionary rates,
because of the low minor allele frequencies and the heter-
Table 3: The biochemical severity of disease-associated mutations, differences among species, and nonsynonymous mutations
Type Number of observations Grantham Distance
Average Std. Error
Disease-associated 7,966 92.06 0.57
Nonsynonymous SNPs 4,022 64.95 0.65
Differences among species 148,558 66.61 0.19
1 -Grantham measure [19] was used to quantify the biochemical distance between amino acids.Page 5 of 9
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terious. Therefore, we estimated the fraction of nSNPs for
which the homozygous recessive genotypes occur with a
non-zero frequency in the human populations examined.
This proportion is the smallest for the highly conserved
sites, and the highest for the most variable positions (Fig-
ure 4B).
The neutral theory also predicts that DAMs at a given posi-
tion will not be the same (amino acid) as fixed differences
between species at that position, as long as the protein
(and position) function remains unchanged over time,
and the DAMs are significantly associated with the disease
phenotype. This proves to be the case for an overwhelm-
ing majority of DAMs, as only 10.4% of them are identical
to inter-specific variations. These proportions are similar
to those reported earlier [11,13]. Overlapping DAMs are
concentrated in the fast-evolving positions, as they con-
tain twice as many of them as the slow-evolving positions
(17% and 9%, respectively; P < 0.01). Therefore, the dis-
tribution of overlapping DAMs is not uniform (Figure
5A).
The overlap between the DAMs and inter-specific differ-
ences is often considered to be caused by the compensa-
tory mutations, where the negative effects of the
mutation(s) at one site of the same or different proteins
compensates for the negative effects of the other mutation
[11,13,21]. It is clear that such mutations need to escape
natural selection for a period of time before the compen-
satory mutations can occur. This may only be possible for
mutations that have very small negative fitness effects, in
Allele and genotype frequencies of non-synonymous SNPs at positions evolving with different evolutionary ratesFigure 4
Allele and genotype frequencies of non-synonymous 
SNPs at positions evolving with different evolution-
ary rates. (A) Relationship of the average minor allele fre-
quencies of the nSNPs with the evolutionary rate (R2 = 0.85, 
P < 0.01) (blue). (B) The proportion of the nSNPs with a 
homozygous minor allele in at least one individual of the 
human population studied (blue). The rate index categories 
were merged into four bins, as mentioned in the Methods.
Average biochemical distances between the amino acid resi-du s found in the normal and diseas  humans and in oth r speciesFigure 3
Average biochemical distances between the amino 
acid residues found in the normal and disease 
humans and in other species. (A) Relationship between 
the average Grantham distances estimated for the DAMs 
(red) and the time of onset of diseases (obtained from [20]). 
The numbers of genes are given in the parenthesis. Error 
bars show the standard error of the mean. (B) Correlation 
between the evolutionary rate and the average Grantham 
distance of the inter-specific amino acid substitutions (R2 = 
0.88, P < 0.01) (green). The average Grantham distance was 
estimated by including all the changes (with respect to the 
human proteins) that occurred in the amino acid positions of 
the non-human proteins belonging to various rate indices. 
Only six rate index categories were included, as the two cat-
egories include only the invariable amino acid positions. 
Error bars show the standard error of the mean.Page 6 of 9
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of overlapping DAMs in fast-evolving positions is consist-
ent with this expectation. The biochemical difference
between the overlapping DAMs and the reference human
amino acid is also consistent with this requirement,
because the biochemical distance of overlapping DAMs is
38% lower than that observed for all other DAMs. In fact,
overlapping DAMs are 14% more conservative than even
the inter-specific variation (see also, [21,22]). Even
though some of the overall patterns mentioned above are
consistent with the compensatory mutation hypothesis,
this is by no means the only or the primary explanation,
because it is unclear what fraction of overlapping DAMs
can be explained by compensatory mutation hypothesis.
In the future, there will be a need to develop statistical
approaches to examine contrasting hypothesis concerning
the existence of overlapping DAMs, including the change
in function of the protein or the position where the over-
lapping DAMs are seen.
Conclusion
Our results emphasize the importance of the long-term
evolutionary history of the amino acid positions and their
influence in modulating the short-term history of the
DAMs and nSNPs. Although our studies are restricted only
to the protein-coding regions, the patterns reported here
will hold true for DAMs and SNPs present in non-coding
DNA containing conserved regulatory regions. Future
studies using more species to examine the evolutionary
conservation of amino acid positions could further
improve the understanding of the mutations associated
with human diseases and population variations. In partic-
ular, use of only the species that are closely related to
humans, such as mammals, or, more specifically, pri-
mates, will prove to be more useful due to the similarity
in their physiology and metabolism.
Methods
Proteomic data
Protein sequences of human (Homo sapiens) were
obtained from GenBank build 34.1 [23], and mouse (Mus
musculus), chicken (Gallus gallus) and fugu (Takifugu
rubripes) were obtained from ensemble [24]. For each
human gene, the putative orthologous gene, or closest
sequence homolog, in the other three vertebrates were
identified using a local BLASTP search with BLOSUM62
substitution matrix [25]. The threshold score (bit score S
in BLASTP program) was set according to protein length
(L): S = 150 for L ≥ 170 amino acids, S = L-20 for 55 <L <
170 and S = 35 for L < 55 amino acids [26]. We used the
reciprocal BLASTP search in which pairs of genes were
considered orthologous only if they were mutually the
best matches in their respective counterpart genomes [12].
We included only the human genes for which an ortholo-
gous counterpart was available in all the three vertebrate
species. Each orthologous gene set was aligned with
CLUSTAL-W using default settings [27]. Only the genes
for which either a disease mutation or nSNP data was
available were included for further analysis. We concate-
nated all the disease-associated genes and all the other
genes (for which SNP data was available) separately, and
all the sites containing any missing data or indels were
excluded from the two concatenated alignments. The rate
of evolution of individual sites was estimated by Maxi-
mum Likelihood analysis using PAML [17] with the JTT
model of evolution. We used a discrete gamma model
(with eight categories) to describe the distribution of evo-
lutionary rates among sites. The complete amino acid
alignments, including indels, were used for computing
the indel index.
Severity and frequency of overlapping DAMsFigu e 5
Severity and frequency of overlapping DAMs. (A) The 
proportion of DAMs that overlap with inter-specific variation 
at positions evolving with different evolutionary rates. Six 
rate index categories that show differences among species 
(Table 1) were pooled into three categories in order to 
make sample sizes large enough, because only 203 DAMs 
show overlap with inter-specific variations. The total number 
of DAMs and the overlapping DAMs are given in parenthesis. 
The hatched area indicates the fraction of DAMs (10.4%) that 
overlap with inter-specific fixed differences over all the varia-
ble amino acid positions (203/1961). (B) The average 
Grantham distance of DAMs (red), inter-specific variations 
(green), and the overlapping mutations (hatched). The num-
bers of mutations and differences are given in parenthesis. 
The error bars show standard error of the mean.Page 7 of 9
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We obtained 20,309 disease-associated mutations in
1,307 human genes from the HGMD database [28], and
29,856 non-synonymous SNPs in 11,753 known human
genes were obtained from the HapMap project, Perlegen
(March, 06), HGVBase (Human Genome Variation Data-
base 17) and TSC (The SNP Consortium, 1). The HGV-
Base and TSC data were obtained through BioMart [24].
We excluded 1,215 mutations that were present in DAM
as well as the SNP data, because public SNP resources may
contain disease mutations even when "healthy" individu-
als are screened, especially when we consider DAMs for
common, late-onset diseases. (We plan to conduct an
analysis of these mutations in the future.) We have
included only the disease mutation or nSNPs for which
the wild-type amino acid and the amino acid in the
human reference sequence (build 34) were the same. We
were able to map 8,627 DAMs (in 541 genes) and 5,308
nSNPs (in 2,592 genes) to the concatenated alignments of
the orthologous sequences using the positional informa-
tion obtained from the respective databases. The allele
and genotype frequencies (used in Figure 4) were availa-
ble only for the HapMap data. The allele and genotype fre-
quencies of synonymous and non-synonymous SNPs are
available for four different ethnic populations (Utah Cau-
casian-Americans, Yoruba Africans, Hans Chinese, and
Tokyo Japanese), and we took the average frequencies of
the four populations. The HapMap SNPs with no varia-
tion in all the four populations (which was determined
from the allele frequencies) were excluded in the analysis.
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